Piel最新文献

筛选
英文 中文
Oclusión vascular por ácido hialurónico de hidratación: una complicación inusual pero posible 透明质酸水合血管闭塞:一种不常见但可能发生的并发症
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2023.12.009
Laura Margarita Arango-Bedoya , Maria Paulina Uribe-Posada , Jaime Rengifo-Palacios
{"title":"Oclusión vascular por ácido hialurónico de hidratación: una complicación inusual pero posible","authors":"Laura Margarita Arango-Bedoya , Maria Paulina Uribe-Posada , Jaime Rengifo-Palacios","doi":"10.1016/j.piel.2023.12.009","DOIUrl":"10.1016/j.piel.2023.12.009","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 338-341"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140783299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granuloma facial tratado con corticoides intralesionales y terapia láser 用皮质类固醇激素和激光治疗面部肉芽肿
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2023.11.012
Victor Meza Viteri , Antonia Mori , Andrés Figueroa
{"title":"Granuloma facial tratado con corticoides intralesionales y terapia láser","authors":"Victor Meza Viteri , Antonia Mori , Andrés Figueroa","doi":"10.1016/j.piel.2023.11.012","DOIUrl":"10.1016/j.piel.2023.11.012","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 371-374"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140789661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eritema pigmentado fijo ampolloso generalizado 泛发性大疱性固定色素性红斑
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2023.12.005
Jose Ricardo Ruiz Cabrera , Rosa Carolina Silva Valencia , Manuela Vargas Osorno , Karen Melissa Sánchez Díaz , María Claudia Carrillo
{"title":"Eritema pigmentado fijo ampolloso generalizado","authors":"Jose Ricardo Ruiz Cabrera , Rosa Carolina Silva Valencia , Manuela Vargas Osorno , Karen Melissa Sánchez Díaz , María Claudia Carrillo","doi":"10.1016/j.piel.2023.12.005","DOIUrl":"10.1016/j.piel.2023.12.005","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 374-377"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140280885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aprobación de biosimilares de ustekinumab: ¿un cambio en la primera línea del tratamiento biológico de la psoriasis? 乌司替尼生物仿制药的批准:银屑病一线生物治疗的变革?
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2024.03.006
Sofia Gómez-Martínez , Daniel Morgado-Carrasco
{"title":"Aprobación de biosimilares de ustekinumab: ¿un cambio en la primera línea del tratamiento biológico de la psoriasis?","authors":"Sofia Gómez-Martínez , Daniel Morgado-Carrasco","doi":"10.1016/j.piel.2024.03.006","DOIUrl":"https://doi.org/10.1016/j.piel.2024.03.006","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 315-316"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141286337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efectividad y seguridad de los fármacos biológicos y las moléculas pequeñas en la hidradenitis supurativa: experiencia en un centro terciario y propuesta de un algoritmo terapéutico 生物制剂和小分子药物治疗化脓性扁桃体炎的有效性和安全性:一家三级中心的经验和治疗算法建议
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2024.02.001
Miguel Mansilla-Polo , Begoña Escutia-Muñoz , David Hervás-Marín , Blanca de Unamuno-Bustos , Carlos Abril-Pérez , Rafael Botella-Estrada
{"title":"Efectividad y seguridad de los fármacos biológicos y las moléculas pequeñas en la hidradenitis supurativa: experiencia en un centro terciario y propuesta de un algoritmo terapéutico","authors":"Miguel Mansilla-Polo ,&nbsp;Begoña Escutia-Muñoz ,&nbsp;David Hervás-Marín ,&nbsp;Blanca de Unamuno-Bustos ,&nbsp;Carlos Abril-Pérez ,&nbsp;Rafael Botella-Estrada","doi":"10.1016/j.piel.2024.02.001","DOIUrl":"10.1016/j.piel.2024.02.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Hidradenitis suppurativa is an occasionally devastating inflammatory skin disease. Currently, adalimumab is the only approved biological or small molecule medication for its treatment.</p></div><div><h3>Objectives</h3><p>To evaluate the efficacy and safety of biological or small molecule drugs other than adalimumab, with the ultimate goal of proposing a standardized therapeutic algorithm.</p></div><div><h3>Methods</h3><p>A retrospective study was conducted with all biological or small molecule drugs other than adalimumab in a tertiary hospital. Objective and subjective measurements were recorded through an analysis before (prior to the introduction of the medication) vs. after (withdrawal of the medication or end of the study period).</p></div><div><h3>Results</h3><p>Better response rates than adalimumab were found in most of the objective response items (Hurley, IHS4, HSSI, modified Sartorius) and subjective response items (DLQI, pain, itching, sexual relationships, therapeutic satisfaction) with infliximab leading, followed by ustekinumab, brodalumab, and secukinumab.</p></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 317-330"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140766903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento del carcinoma basocelular localmente avanzado con vismodegib e itraconazol como coadyuvante 用 vismodegib 和伊曲康唑辅助治疗局部晚期基底细胞癌
Piel Pub Date : 2024-06-01 DOI: 10.1016/j.piel.2023.12.011
Sara Muñoz-Ordoñez, Jesús D. Fierro-Lozada, Laura Yiseth Calderón-Acero, Paola Andrea Russy-Buitrago, Neissen Nathaly Lozano-Reay, David A. Castillo-Molina
{"title":"Tratamiento del carcinoma basocelular localmente avanzado con vismodegib e itraconazol como coadyuvante","authors":"Sara Muñoz-Ordoñez,&nbsp;Jesús D. Fierro-Lozada,&nbsp;Laura Yiseth Calderón-Acero,&nbsp;Paola Andrea Russy-Buitrago,&nbsp;Neissen Nathaly Lozano-Reay,&nbsp;David A. Castillo-Molina","doi":"10.1016/j.piel.2023.12.011","DOIUrl":"10.1016/j.piel.2023.12.011","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 6","pages":"Pages 377-379"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mucinosis eritematosa reticular: descripción clínica y retos terapéuticos 网状红斑粘蛋白病:临床描述和治疗难题
Piel Pub Date : 2024-05-22 DOI: 10.1016/j.piel.2024.02.003
{"title":"Mucinosis eritematosa reticular: descripción clínica y retos terapéuticos","authors":"","doi":"10.1016/j.piel.2024.02.003","DOIUrl":"10.1016/j.piel.2024.02.003","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 8","pages":"Pages 522-524"},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141144639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No todo es efluvio telógeno. Alopecia areata difusa una entidad infradiagnosticada 并非所有脱发都是毛囊性脱发。弥漫性脱发诊断不足
Piel Pub Date : 2024-05-22 DOI: 10.1016/j.piel.2024.01.018
{"title":"No todo es efluvio telógeno. Alopecia areata difusa una entidad infradiagnosticada","authors":"","doi":"10.1016/j.piel.2024.01.018","DOIUrl":"10.1016/j.piel.2024.01.018","url":null,"abstract":"<div><div>The accurate differentiation between diffuse alopecia areata (DAA) and telogen effluvium (TE) is paramount in clinical dermatological practice due to the implications in therapeutic management and prognosis for the patient. Although both conditions might showcase similar clinical features, such as diffuse hair loss, their underlying etiologies and mechanisms are distinct. DAA is an autoimmune condition wherein the immune system targets the hair follicles, whereas TE is a temporary response to a physiological or stress-related shock, resulting in a synchronized telogen phase and subsequent hair shedding. Properly diagnosing and distinguishing these two conditions is not only crucial for setting an appropriate treatment course but also for guiding patients regarding long-term expectations. This article emphasizes the significance of correctly recognizing and differentiating DAA from TE, underlining the clinical impact of a misdiagnosis and the need for more efficient diagnostic tools in the dermatological field.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 8","pages":"Pages 495-502"},"PeriodicalIF":0.0,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141140003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlación dermatoscópica e histopatológica de la acropigmentación de Dohi 皮肤镜和组织病理学对多希氏色素沉着的相关性研究
Piel Pub Date : 2024-05-10 DOI: 10.1016/j.piel.2024.02.005
{"title":"Correlación dermatoscópica e histopatológica de la acropigmentación de Dohi","authors":"","doi":"10.1016/j.piel.2024.02.005","DOIUrl":"10.1016/j.piel.2024.02.005","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 8","pages":"Pages 524-526"},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paederosis 肤色
Piel Pub Date : 2024-05-10 DOI: 10.1016/j.piel.2024.01.016
{"title":"Paederosis","authors":"","doi":"10.1016/j.piel.2024.01.016","DOIUrl":"10.1016/j.piel.2024.01.016","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"39 8","pages":"Pages 503-505"},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141050684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信